Large gap with delayed quotes
Analysis date: 10.02.2026
Global Evaluation
Neutral
Neutral
The stock is classified in the neutral zone since 14.11.2025.
Interest
Very strong
Very strong
Four stars since 13.01.2026.
Earnings Rev Trend
Positive
Positive
Compared to seven weeks ago, the analysts have raised their earnings per share estimates. This positive trend began 06.01.2026 at a price of 252.20.
Evaluation
Strongly undervalued
Strongly undervalued
Based on its growth potential and our own criteria, we believe the share price is currently undervalued.
MT Tech Trend
Positive
Positive
The dividend-adjusted forty day technical trend is positive since 06.01.2026.
4wk Rel Perf
2.15%
2.15%
The four-week dividend-adjusted overperformance versus STOXX600 is 2.15%.
Sensibility
Middle
Middle
The stock has been on the moderate-sensitivity level since 14.11.2025.
Bear Market Factor
Middle
Middle
On average, the stock is likely to decline with the index.
Bad News Factor
Low
Low
When the stock's pressure is specific, the market sanction on average is 2.85%.
Mkt Cap in $bn
60.18
60.18
With a market capitalization >$8bn, UCB is considered a large-cap stock.
G/PE Ratio
1.54
1.54
A "Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings" ratio higher than 1.5 indicates that the stock's price presents a discount to growth >40% in this case.
LT P/E
14.04
14.04
The estimated PE is for the year 2028.
LT Growth
21.00%
21.00%
The annualized growth estimate is for the current year to 2028.
Avg. Nb analysts
12
12
Over the last seven weeks, an average of 12 analysts provided earnings per share estimates.
Dividend Yield
0.55%
0.55%
The twelve month estimated dividend yield represents 7.71% of earnings forecasts.
Beta
148
148
For 1% of index variation, the stock varies on average by 1.48%.
Correlation
0.52
0.52
51.86% of stock movements are explained by index variations.
Value at Risk
61.55
61.55
The value at risk is estimated at EUR 61.55. The risk is therefore 23.23%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
02.01.2002
02.01.2002